Share Name Share Symbol Market Type Share ISIN Share Description
Evgen Pharma Plc LSE:EVG London Ordinary Share GB00BSVYN304 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 7.45 7.30 7.60 7.45 7.45 7.45 66,656 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -3.1 -2.7 - 10

Evgen Pharma Share Discussion Threads

Showing 1801 to 1822 of 1850 messages
Chat Pages: 74  73  72  71  70  69  68  67  66  65  64  63  Older
DateSubjectAuthorDiscuss
12/11/2019
20:54
Dave I would personally see a fund raise as a positive. It means wealthy individuals think the company is still worth their money, while also strengthens the companies financial position giving it more options and more time. If anyone is in panic mode to be honest it sounds like you are.
asat91
12/11/2019
20:52
This share will go up from here and I would not be surprised if significant shareholders were buying right now
dave444
12/11/2019
20:51
Another that is in panic or manipulation mode!They were looking for partners after the breast cancer results which happens to be the biggest problem and dwarfs SAH!
dave444
12/11/2019
20:48
Dave, it is not a question of people misunderstanding that statement - it is a question of restoring shareholder faith at this stage. Whether enough progress will be made in the next 12 months or so within the existing budget to mean no further fund raise(s) will be necessary/in sufficient time for a partner to buy in without too much of an impact on existing shareholders etc. We have all seen what can happen with a stock like this on terrible news. I hope this is not now going to become a lifestyle company for the BOD (seen that before elsewhere, but not in the capacity of an investor thankfully) - but they need to really step up now and IMO some share purchases would not go amiss as part of a package of measures to restore 'shareholder value' rather than just the typical corporate speak. The next few weeks will probably tell us all we need to know...
lovewinshatelosses
12/11/2019
20:48
What a player you are!
dave444
12/11/2019
20:47
You can try to scare but the answer is no!
dave444
12/11/2019
20:45
Well the company won't wait until they have £1 left to raise more money. Would expect perhaps early 2020 or mid 2020 for a fund raise if they don't get money from a breast cancer agreement.
asat91
12/11/2019
17:17
The company have said they are funded to Mid 2021 why can people not understand that?
dave444
12/11/2019
16:34
To be honest nobby, that is what is keeping me here still (sitting on significant paper losses) - although I was expecting maybe a 30% drop with bad SAH results, not this, given where things are in terms of the breast cancer play. As others have said, I guess the fear of that also turning out to be a dud, and/or risk of heavy dilution from a further placing, is why we are where we are currently. Oh well, I did say I entered these types of small cap investments with the mindset of being ready for complete capital wipeout as a worst case scenario, so I am walking (hobbling) the walk... :)
lovewinshatelosses
12/11/2019
15:16
The SAH result in now way should undermine the breast cancer result as patently it is a completely different MOA. Sulforaphane is known to hit multiple pathways.
nobbygnome
12/11/2019
15:15
Clearly an overreaction as they have £7m in cash and state they are funded for all activities to mid 2021 another 18 months.On top of that they were looking at a partner deal.In the April presentation it states a typical forward payment of $50m on the breast cancer indication so let's see if this happens!
dave444
12/11/2019
15:14
Definitely undervalued IMHO in comparison with other similar companies. I guess the worry is another fund raising if they need to do a further trial themselves, although I suspect they will be stepping up licensing discussions now.
nobbygnome
12/11/2019
15:06
It is an interesting opportunity this because it's a pharma with an asset that has positive data in one indication at phase II, and non-significant (negative data) in another indication at phase II. Does the negative data for SAS indication warrant a share price drop of 60%, and a market cap of 10 million? Is 10 million fair value for what the company has at the moment? That's the golden question. Maybe the answer is yes, maybe it is no. What do you think?
asat91
12/11/2019
13:15
Oh dear the moron is back the late shorter who cannot get his return
dave444
12/11/2019
11:34
How low can this go
shirley83
12/11/2019
10:48
Does anyone know how soon a major shareholder has to declare a change of their holding? I had a feeling it was within a few days when it breaches certain percentages in either direction, but I could be wrong about that (like some of my investment decisions, ahem!).
lovewinshatelosses
11/11/2019
17:24
I hope he enjoys his sleep tonight! Lol!
dave444
11/11/2019
17:18
Another fantasy trader I see...
nobbygnome
11/11/2019
17:09
why? I prefer to keep my positions quiet till it's big. I did not say I was short, till you said I was short today. Merely correcting your inaccurate false statement. tomorrow sub 5p very likely. I would even say sub 3p by Friday. No one coming to the Rescue, no point red marking. Is it not inconceivable they will raise cash now, when it's easier rather than putting the begging bowl at 2p?
mega bozzer
11/11/2019
17:07
If you had been short for a few weeks I think you would have mentioned it before
dave444
11/11/2019
17:06
That's funny, £I am underwater". I believe you are are drowning with "locked and loaded" posts. just -50% just today. In the morning it was closer to -65%.
mega bozzer
11/11/2019
17:05
a row of sells, cumulative about 224K. Not one single for 2 hours. I am not desperate been short for a few weeks. Just today I am up 50% on this position.
mega bozzer
Chat Pages: 74  73  72  71  70  69  68  67  66  65  64  63  Older
Your Recent History
LSE
EVG
Evgen Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191214 00:20:00